Dissemin is shutting down on January 1st, 2025

Links

Tools

Export citation

Search in Google Scholar

Tonic Inhibition of Accumbal Spiny Neurons by Extrasynaptic α4βδ GABA<sub>A</sub>Receptors Modulates the Actions of Psychostimulants

This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Question mark in circle
Preprint: policy unknown
Question mark in circle
Postprint: policy unknown
Question mark in circle
Published version: policy unknown

Abstract

Within the nucleus accumbens (NAc), synaptic GABA A receptors (GABA A Rs) mediate phasic inhibition of medium spiny neurons (MSNs) and influence behavioral responses to cocaine. We demonstrate that both dopamine D1- and D2-receptor-expressing MSNs (D-MSNs) additionally harbor extrasynaptic GABA A Rs incorporating α4, β, and δ subunits that mediate tonic inhibition, thereby influencing neuronal excitability. Both the selective δ-GABA A R agonist THIP and DS2, a selective positive allosteric modulator, greatly increased the tonic current of all MSNs from wild-type (WT), but not from δ -/- or α4 -/- mice. Coupling dopamine and tonic inhibition, the acute activation of D1 receptors (by a selective agonist or indirectly by amphetamine) greatly enhanced tonic inhibition in D1-MSNs but not D2-MSNs. In contrast, prolonged D2 receptor activation modestly reduced the tonic conductance of D2-MSNs. Behaviorally, WT and constitutive α4 -/- mice did not differ in their expression of cocaine-conditioned place preference (CPP). Importantly, however, mice with the α4 deletion specific to D1-expressing neurons (α4 D1-/- ) showed increased CPP. Furthermore, THIP administered systemically or directly into the NAc of WT, but not α4 -/- or α4 D1-/- mice, blocked cocaine enhancement of CPP. In comparison, α4 D2-/- mice exhibited normal CPP, but no cocaine enhancement. In conclusion, dopamine modulation of GABAergic tonic inhibition of D1- and D2-MSNs provides an intrinsic mechanism to differentially affect their excitability in response to psychostimulants and thereby influence their ability to potentiate conditioned reward. Therefore, α4βδ GABA A Rs may represent a viable target for the development of novel therapeutics to better understand and influence addictive behaviors.